





KidneyUrinary Markers of Oxidative Stress
Are Associated With Albuminuria
But Not GFR Decline
Jørgen Schei1,2, Ole-Martin Fuskevåg3, Vidar Tor Nyborg Stefansson2, Marit Dahl Solbu1,2,
Trond Geir Jenssen2,4, Bjørn Odvar Eriksen1,2 and Toralf Melsom1,2
1Department of Nephrology, University Hospital of North Norway, Tromsø, Norway; 2Metabolic and Renal Research Group,
UiT The Arctic University of Norway, Tromsø, Norway; 3Department of Laboratory Medicine, University Hospital of North
Norway, Tromsø, Norway; and 4Department of Transplant Medicine, Oslo University Hospital, Oslo, NorwayIntroduction: Markers of oxidative stress increase with age and are prevalent with chronic kidney disease.
However, the role of oxidative stress markers as predictors for kidney function decline in the general
population is unclear.
Methods: We investigated whether a baseline urinary excretion of oxidative DNA damage (8-oxo-7,8-
dihydro-20-deoxyguanosine [8-oxodG]) and oxidative RNA damage (8-oxo-7,8-dihydroguanosine [8-
oxoGuo]) was associated with the age-related glomerular filtration rate (GFR) decline or incident
low-grade albuminuria during a median of 5.6 years of follow-up. In the Renal Iohexol Clearance Survey in
the Sixth Tromsø Study, we measured GFR using iohexol clearance in 1591 participants without renal
disease, diabetes, or cardiovascular disease. Low-grade albuminuria was defined as an albumin-creatinine
ratio >1.13 mg/mmol.
Results: The mean (SD) annual GFR change was 0.84 (2.00) ml/min per 1.73 m2 per year. In linear mixed
models, urinary 8-oxodG and 8-oxoGuo levels were not associated with the GFR change rate. In a
multivariable adjusted logistic regression model, a baseline urinary 8-oxoGuo in the highest quartile was
associated with an increased risk of low-grade albuminuria at follow-up (odds ratio: 2.64; 95% confidence
interval: 1.50–4.65). When the highest quartile of urinary 8-oxoGuo was added to the baseline model, the
area under the receiver operating characteristics curve for predicting low-grade albuminuria at follow-up
improved from 0.67 to 0.71 (P ¼ 0.002).
Conclusion: Oxidative stress measured as urinary 8-oxoGuo excretion was independently associated with
incident low-grade albuminuria, but neither 8-oxoGuo nor 8-oxodG predicted an accelerated age-related
GFR decline in a cohort representative of the middle-aged general population during almost 6 years of
follow-up.
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ge-related glomerular filtration rate (GFR) decline
is an important cause of the high prevalence of
chronic kidney disease (CKD) found in old age.1,2 CKD
is a strong risk factor for cardiovascular disease, end-
stage renal disease, and mortality3; however, there is
a considerable interindividual variation in the age-
related GFR decline, even after accounting for tradi-
tional CKD risk factors, such as hypertension and
diabetes.4,5 Identifying novel risk factors for early
kidney dysfunction, such as accelerated GFR declinespondence: Jørgen Schei, Section of Nephrology, University
tal of North Norway, N-9038 Tromsø, Norway. E-mail:
schei@gmail.com
ved 29 June 2017; revised 17 November 2017; accepted 29
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International Reports (2018) 3, 573–582or low-grade albuminuria, may suggest underlying
pathologic mechanisms and prompt the development
of an early and targeted treatment for the prevention
of CKD.6
Oxidative stress is defined as a condition in which
the generation of reactive species exceeds the antioxi-
dant repair and defense system, leading to tissue
damage. It increases with age and is associated with the
pathogenesis of several age-related chronic diseases.7
Experimental studies show that oxidative stress in-
duces inflammation, endothelial dysfunction, mito-
chondrial dysfunction, fibrosis, and accelerated kidney
function decline in animal kidneys.8–10 In humans,
cross-sectional studies show that higher levels of
oxidative stress markers are associated with an
increased severity of CKD.11–16 Particularly, oxidative573
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mation of 8-oxo-7,8-dihydro-20-deoxyguanosine (8-
oxodG), is proposed to promote age-related degenera-
tive processes in the kidneys.10,17,18 The proximal
tubular cells in the kidneys are particularly susceptible
to oxidative DNA damage, due to their large number of
mitochondria. Urinary levels of 8-oxodG and 8-oxo-7,8-
dihydroguanosine (8-oxoGuo) are established markers
of oxidative DNA and RNA damage, respectively, as
well as total systemic oxidative stress.19,20 Prospective
studies of the association of urinary 8-oxodG and 8-
oxoGuo excretion with kidney dysfunction are scarce
and have not been conducted in the general popula-
tion. We measured GFR as iohexol clearance at baseline
and follow-up in the Renal Iohexol Clearance Survey
Follow-Up Study (RENIS-FU), which is the largest
longitudinal population-based cohort with accurate
measurements of GFR.21 The aim of this study was to
investigate whether higher urinary levels of 8-oxodG
and 8-oxoGuo predicted a faster age-related GFR
decline or low-grade albuminuria during 6 years of
follow-up.MATERIALS AND METHODS
Study Participants
The Renal Iohexol Clearance Survey in the Sixth
Tromsø Study (RENIS-T6) is a substudy of the
population-based Sixth Tromsø Study and was per-
formed between October 2007 and June 2009. It
included a representative sample from the general
population of 1627 persons aged 50 to 62 years withoutn = 1627
The RENIS-T6 cohort
n = 1591
Baseline study participants in the current
study
n = 1298
Study participants at follow-up
Figure 1. Flowchart of the study participants in the Renal Iohexol Clear
Follow-Up Study.
574self-reported cardiovascular disease, diabetes, or kid-
ney disease. There were 826 women and 801 men. A
detailed description of the study is published else-
where.22 All of the participants in the RENIS-T6 were
invited to the RENIS-FU, except for 23 participants
who had died and 7 who had a possible delayed allergic
reaction to iohexol.
The RENIS-FU was performed between September
2013 and January 2015. Of the 1597 subjects invited,
1368 gave a positive response. Five participants were
excluded because of problems with the cannulation of
the antecubital vein, and 39 participants did not meet
at their appointments. We excluded 33 participants
who were diagnosed with diabetes at baseline (fasting
glucose $ 7.0 mmol/l and/or hemoglobin A1c
[HbA1c] $6.5%) and an additional 3 participants with
missing 8-oxodG and 8-oxoGuo values, leaving 1298
(81%) participants with a follow-up measurement in
the current study (Figure 1).
The study adhered to the Declaration of Helsinki,
and the Regional Ethics Committee of Northern Nor-
way approved it. All participants gave informed
written consent.
Data
The measurements in RENIS-T6 and RENIS-FU were
performed at the Clinical Research Unit at the Univer-
sity Hospital of North Norway. The participants met
between 8 and 10 AM. They were instructed to avoid
large meals with meat and to avoid taking nonsteroidal
anti-inflammatory drugs during the preceding 48
hours, in addition to fast and abstain from smokingn = 36
Diabetes (fasting blood glucose ≥
7.0 mmol/l and/or HbA1c ≥ 6.5%)
n = 293
Lost to follow-up
(n=33) or missing values of 8-
oxodG/8-oxoGuo (n=3)
ance Survey in the Sixth Tromsø Study (RENIS-T6) and the RENIS
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with an acute illness were rescheduled to another
appointment. All participants answered a questionnaire
about their current alcohol, tobacco, and medication
use. Tobacco use was dichotomized as current smoker
or as a continuous variable (the number of cigarettes
currently smoked) in the regression model analyses.
Alcohol use was dichotomized as the use of alcohol
more than once weekly.Measurements
The urinary levels of 8-oxodG and 8-oxoGuo were
measured by liquid chromatography tandem mass
spectrometry. The Supplemental Material provides a
more detailed description of the analysis. A second
void morning spot urine after an overnight fast was
collected at baseline in RENIS-T6. The samples were
centrifuged, and the supernatant was immediately put
on ice and frozen at 80C within a few hours. The
frozen urine samples were thawed and mixed before
the liquid chromatography tandem mass spectrometry
analysis. The 8-oxodG and 8-oxoGuo were obtained
from Cayman Chemical Co. (Ann Arbor, MI). The in-
ternal standard 8-oxodG (15N5, 98%) was purchased
from Cambridge Isotope Laboratories, Inc. (Andover,
MA). Water was obtained from a Millipore Advantage
Milli-Q system (Millipore SAS, Molsheim, France).
Synthetic urine was prepared according to the method
of Kark et al.23 with some modifications. The samples
were prepared by adding 50 ml of a 50-nM aqueous
internal standard (8-oxodG, 15N5, 98%) to 60 ml urine
in a 1-ml collection plate (Waters, Milford, MA). To
each of the wells, 500 ml 0.1% formic acid was then
added and mixed. The samples were analyzed by liquid
chromatography tandem mass spectrometry using the
Waters Acquity UPLC I-class system with an auto-
sampler and a binary solvent delivery system (Waters,
Milford, MA) interfaced to the Waters Xevo TQ-S
benchtop tandem quadrupole mass spectrometer (Wa-
ters, Manchester, UK).
The concentrations of 8-oxodG and 8-oxoGuo were
normalized for urinary creatinine (8-oxodGUCR and 8-
oxoGuoUCR). The between-day coefficients of varia-
tion (CVs) for 8-oxodGUCR and 8-oxoGuoUCR
were #5.7% at 21 different days and were calculated
using the quality controls (QCs). The concentrations for
the high and low QCs were 50 nmol/l and 5 nmol/l,
respectively. The intraday precision values were
calculated by assaying 6 different urine samples 6 times
on the same day. The CVs for both markers
were <5.5%. The interassay CVs for 8-oxodGUCR and
8-oxoGuoUCR during the measurements were 4.7% and
3.8% for the lowest QC and 4.1% and 5.1% for theKidney International Reports (2018) 3, 573–582highest QC, respectively. The intra-assay CVs for 8-
oxodGUCR and 8-oxoGuoUCR were 3.6% and 3.7% for
the lowest QC and 2.4% and 3.3% for the highest QC,
respectively.
The GFR was measured using a single-sample clear-
ance of plasma iohexol at both baseline and follow-up.
The single-sample iohexol clearance was validated
against gold standard methods for measuring the
GFR.24 A detailed description of the GFR measurement
is published elsewhere.22 The CV for the analysis was
3.0% at baseline and 3.1% at follow-up. There was a
mean difference of 2.28 ml/min per 1.73 m2 between
the baseline GFR measurements in RENIS-T6 and the
repeated baseline measurements of the thawed samples.
Accordingly, all of the baseline GFR measurements
were corrected by adding this difference to the baseline
values, as described previously.21 A random sample of
5.5% of the subjects in the follow-up study had an
additional GFR measurement after 2 weeks and within
2 months to investigate intra-individual variation in
the measurements. The mean CV (95% confidence in-
terval) for the intra-individual (day-to-day) variation of
the GFR was 4.2% (3.4%–4.9%).21In the RENIS-T6 and
RENIS-FU, 3 samples of the first-void morning spot
urine were collected on separate days. The urinary
excretion of albumin and creatinine were measured in
unfrozen urine samples. The urine albumin to creati-
nine ratio (UACR) was calculated for each of the urine
samples, and the mean values were used in the analysis.
Low-grade albuminuria was defined as a UACR >1.13
mg/mmol (>10 mg/g), according to the “high-normal
albuminuria” cutoff proposed by the CKD Prognosis
Consortium.25,26 Blood pressure, fasting serum glucose,
triglycerides, high-density lipoprotein cholesterol,
low-density lipoprotein cholesterol, and hemoglobin
A1c were measured with standard methods as previ-
ously described.27
Statistical Analyses
The baseline and follow-up characteristics are pre-
sented as the means (SD), medians (interquartile
range) for skewed variables, and numbers (percent).
Differences between the participants included in the
follow-up study and those lost to follow-up were
tested with the 2 independent samples t-test,
Wilcoxon-Mann-Whitney test, and c2 or Fisher exact
test, as appropriate. A linear trend over the increasing
quartiles of 8-oxodG and 8-oxoGuo was tested with
linear and median regression for continuous variables
and with logistic regression for dichotomous vari-
ables. For the mixed model and the logistic regression
analyses, we used continuous and quartiles of 8-
oxodGUCR and 8-oxoGuoUCR levels as independent
variables in separate models. Quartile 1 was used as a575
CLINICAL RESEARCH J Schei et al.: Urinary Markers of Oxidative Stress and Kidney Function Declinereference. In addition, we compared persons with the
highest quartile of 8-oxodGUCR/8-oxoGuoUCR with the
3 lowest quartiles.
The associations of the oxidative stress markers
with the annual GFR change were examined in a
linear mixed regression model with a random inter-
cept and slope.28 GFR, standardized to body surface
area (ml/min per 1.73 m2), was used as the dependent
variable. The time from baseline to follow-up was
used as the time variable. The associations of the
oxidative stress markers with the GFR decline rate
were modeled as interactions between the oxidative
stress markers and the time variable. All of the 1591
subjects at baseline, as well as the extra follow-up
measurements of the GFR for 5.5% of the partici-
pants, were included in the model because a linear
mixed regression model allows missing observations
at 1 or more points in time.29 We included 3 models
that were adjusted as follows: model 1 was unad-
justed; model 2 was adjusted for sex, baseline age,
body weight, and height; and model 3 was addition-
ally adjusted for baseline diastolic blood pressure,
high-density lipoprotein cholesterol, low-density li-
poprotein cholesterol, fasting triglycerides, HbA1c,
high-sensitivity C-reactive protein (hs-CRP), a
dichotomous variable for the weekly use of alcohol,
the number of cigarettes currently smoked, UACR,
and the use of angiotensin-converting enzyme in-
hibitors and angiotensin receptor blockers.
The odds ratio for incident low-grade albuminuria
was analyzed using logistic regression models with the
same adjustment variables described previously,
except that the UACR was replaced with baseline GFR
in model 3. In these analyses, persons with baseline
low-grade albuminuria were excluded (n ¼ 122). To
evaluate the classification power of 8-oxoGuoUCR for
predicting low-grade albuminuria at follow-up, we
compared the area under the receiver operating char-
acteristics curve for the logistic regression models, with
and without 8-oxoGuoUCR, using the likelihood test.
Statistical significance was defined as P < 0.05. The
analyses were performed with STATA 14 (www.stata.
com) (StataCorp, College Station, TX).RESULTS
The RENIS-T6 Study consisted of 1627 subjects aged 50
to 62 years without self-reported kidney disease, dia-
betes mellitus, or cardiovascular disease. We excluded
33 persons who fulfilled diagnostic criteria for diabetes
mellitus at baseline (fasting glucose $7.0 mmol/l or
HbA1c$6.5%) and 3 persons with missing 8-oxodG/8-
oxoGuo values, leaving 1591 persons at baseline in the
current study. After a median (interquartile range) of5765.6 (5.2–6.0) years, 1298 persons were included in the
RENIS-FU Study (Figure 1).
The median (interquartile range) concentrations of
8-oxodGUCR and 8-oxoGuoUCR were 1.36 (1.04–1.74)
nmol/mmol and 3.45 (2.68–4.44) nmol/mmol, respec-
tively. The urinary levels of 8-oxodG and 8-oxoGuo
were higher in men compared with women, but
were lower in men after correction for urinary creat-
inine. Thus, we sex-adjusted the baseline character-
istics of the study population according to the
quartiles of 8-oxodGUCR and 8-oxoGuoUCR, as shown
in Tables 1 and 2. Higher quartiles of both markers
were associated with a higher age and with current
smoking. There were no statistically significant cross-
sectional associations of 8-oxodGUCR and 8-oxoGuoUCR
with either GFR or UACR at baseline. The study
participants with higher quartiles of 8-oxoGuoUCR had
an unfavorable metabolic profile (higher weight, body
mass index, fasting glucose, hs-CRP, and lower high-
density lipoprotein cholesterol). There was a signifi-
cant positive correlation between 8-oxodG and
8-oxoGuo (R ¼ 0.75, P < 0.001; Figure 2), which was
attenuated when using 8-oxodGUCR and 8-oxoGuoUCR
(R ¼ 0.39, P < 0.001). There were small differences
between those included in the follow-up study and
those lost to follow-up (Supplementary Table S1),
except for the current smoking status (19% vs. 28%,
P < 0.001) and a higher 8-oxoGuoUCR level in the
group lost to follow-up (3.62 nmol/mmol vs. 3.42
nmol/mmol, P ¼ 0.02).
The unadjusted mean (SD) GFR change rate during
the study period was 0.84 (2.00) ml/min per 1.73 m2
per year. We examined the associations of the oxidative
stress markers with the annual GFR change rate in 3
separate linear mixed regression models, as shown in
Table 3. The levels of urinary 8-oxodGUCR and 8-
oxoGuoUCR were not associated with the annual GFR
decline. We did not find any significant nonlinear as-
sociations when the same models as described previ-
ously were analyzed with fractional polynomial
transformations. We then examined the risk of a rapid
GFR decline, defined as an annual GFR loss >3.0 ml/
min per 1.73 m2 (n ¼ 133), and the risk of low GFR,
defined as GFR <60 ml/min per 1.73 m2 at follow-up
(n ¼ 26), as dichotomous outcomes in separate logistic
regression models with an adjustment for the same
variables as in the linear mixed models. Neither 8-
oxodGUCR nor 8-oxoGuoUCR was associated with an
increased risk of rapid GFR decline or low GFR (data
not shown).
Table 4 shows results of the unadjusted and multi-
variable adjusted logistic regression analyses for the
risk of incident low-grade albuminuria. In total, 46
persons developed incident low-grade albuminuriaKidney International Reports (2018) 3, 573–582
Table 1. The baseline study population characteristics according to the quartile of urinary 8-oxodG: The Renal Iohexol Clearance Survey
Follow-Up Study
Baseline characteristics
Quartile of 8-oxodG, range (nmol/mmol creatinine)
P for linear trenda
Quartile 1 (n [ 397) Quartile 2 (n [ 398) Quartile 3 (n [ 398) Quartile 4 (n [ 398)
(0.20--1.04) (1.05--1.36) (1.37--1.73) (1.74--5.15)
Men, % 65.7 56.0 43.7 30.4 <0.001
Age baseline, yr 57.2 (3.9) 58.1 (3.8) 58.3 (3.8) 58.6 (3.9) <0.001
Body mass index, kg/m2 27.4 (4.0) 27.5 (3.9) 27.1 (3.9) 26.8 (4.0) 0.10
GFR,b ml/min per 1.73 m2 93.5 (14.0) 93.1 (13.8) 94.7 (13.8) 93.9 (14.0) 0.40
Systolic blood pressure, mm Hg 128.9 (17.3) 129.6 (17.1) 130.0 (17.0) 129.2 (17.3) 0.80
Diastolic blood pressure, mm Hg 83.8 (9.5) 83.9 (9.4) 83.2 (9.4) 82.6 (9.6) 0.23
Fasting glucose, mmol/l 5.32 (0.47) 5.33 (0.46) 5.34 (0.46) 5.28 (0.47) 0.26
Hemoglobin A1c, % 5.54 (0.34) 5.54 (0.33) 5.54 (0.33) 5.52 (0.34) 0.74
HDL-cholesterol, mmol/l 1.53 (0.40) 1.53 (0.40) 1.55 (0.40) 1.55 (0.40) 0.79
LDL-cholesterol, mmol/l 3.76 (0.87) 3.64 (0.86) 3.68 (0.86) 3.58 (0.87) 0.04
High-sensitivity C-reactive protein, mg/l 1.20 (1.07–1.34) 1.16 (1.03–1.30) 1.19 (1.06–1.33) 1.17 (1.04–1.31) 0.98
Triglycerides, mmol/l 1.00 (0.70–1.40) 1.00 (0.70–1.50) 1.10 (0.80–1.40) 1.10 (0.80–1.50) 0.09
Urinary albumin-creatinine ratio, mg/mmol 0.22 (0.15–0.28) 0.25 (0.19–0.31) 0.20 (0.14–0.27) 0.26 (0.19–0.32) 0.59
ACEi, % 2.9 2.9 4.9 3.9 0.46
ARB, % 13.6 16.2 18.3 13.5 0.28
Current smoker, % 14.0 15.5 23.4 28.8 <0.001
Alcohol consumption, % 29.9 36.1 23.7 33.3 0.42
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density.
lipoprotein; 8-oxodG, 8-oxo-7,8-dihydro-20-deoxyguanosine.
Numbers were adjusted for sex and are presented as mean (SD), median (interquartile range), and percent.
aLinear trend over increasing quartiles of urinary 8-oxodG was adjusted for gender.
bGFR was measured by iohexol clearance.
J Schei et al.: Urinary Markers of Oxidative Stress and Kidney Function Decline CLINICAL RESEARCHdefined as a UACR between 1.13 and 3.4 mg/mmol and
8 developed a UACR level between 3.4 and 19.0 mg/
mmol (lower range of albuminuria) at follow-up. These
were analyzed together as 1 low-grade albuminuria




Quartile 1 (n [ 397) Quartile 2 (n [ 3
(0.73--2.68) (2.69--3.45)
Men, % 59.4 52.8
Age baseline, yr 57.0 (3.8) 58.1 (3.8
Body mass index, kg/m2 26.5 (3.9) 27.0 (3.9
GFR,b ml/min per 1.73 m2 94.4 (13.9) 93.4 (13.
Systolic blood pressure, mm Hg 129.2 (17.1) 129.8 (17.
Diastolic blood pressure, mm Hg 83.5 (9.4) 83.4 (9.4
Fasting glucose, mmol/l 5.25 (0.46) 5.30 (0.4
Hemoglobin A1c, % 5.51 (0.33) 5.52 (0.3
HDL-cholesterol, mmol/l 1.57 (0.40) 1.56 (0.3
LDL-cholesterol, mmol/l 3.57 (0.86) 3.68 (0.8
High-sensitivity C-reactive protein, mg/l 1.03 (0.90–1.17) 1.16 (1.03–1
Triglycerides, mmol/l 1.00 (0.90–1.10) 1.00 (0.90–1
Urinary albumin-creatinine ratio, mg/mmol 0.16 (0.10–0.22) 0.25 (0.19–0
ACEi, % 3.4 4.9
ARB, % 12.3 17.6
Current smoker, % 12.2 22.2
Alcohol consumption, % 36.7 33.5
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; GFR, glome
lipoprotein; 8-oxoGuo, 8-oxo-7,8-dihydroguanosine.
Numbers were adjusted for sex and are presented as mean (SD), median (interquartile range
aLinear trend over increasing quartiles of urinary 8-oxoGuo was adjusted for gender.
bGFR was measured by iohexol clearance.
Kidney International Reports (2018) 3, 573–582albuminuria when 8-oxodGUCR was used as a contin-
uous variable in the unadjusted analyses, but after an
adjustment for age, gender, weight, and height, this
association was not statistically significant. For 8-
oxoGuoUCR, there was a statistically significant trendquartile of urinary 8-oxoGuo: The Renal Iohexol Clearance Survey
uo, range (nmol/mmol creatinine)
P for linear trenda
98) Quartile 3 (n [ 398) Quartile 4 (n [ 398)
(3.46--4.44) (4.45--13.4)
42.5 42.2 <0.001
) 58.5 (3.8) 58.6 (3.8) <0.001
) 27.6 (3.9) 27.7 (3.9) <0.001
8) 92.8 (13.8) 94.5 (13.8) 0.23
0) 130.0 (17.1) 128.7 (17.1) 0.69
) 83.5 (9.4) 83.0 (9.4) 0.89
6) 5.34 (0.46) 5.39 (0.46) <0.001
3) 5.57 (0.33) 5.55 (0.33) 0.05
9) 1.52 (0.40) 1.49 (0.40) 0.03
6) 3.69 (0.86) 3.72 (0.86) 0.07
.30) 1.17 (1.04–1.31) 1.39 (1.25–1.53) 0.003
.10) 1.10 (1.00–1.20) 1.10 (1.00–1.20) 0.29





rular filtration rate; HDL, high-density lipoprotein; LDL, low-density.
), and percent.
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Figure 2. Scatterplot of the correlation between the urinary log 8-oxoGuo and log 8-oxodG.
CLINICAL RESEARCH J Schei et al.: Urinary Markers of Oxidative Stress and Kidney Function Declinefor higher odds ratios with increasing quartiles in all
models (P < 0.02). When comparing the highest
quartile of 8-oxoGuoUCR with the lowest 3 quartiles,
the odds ratio was 2.64 (95% confidence interval:
1.50–4.65) in the unadjusted analyses. After multivar-
iable adjustments, including baseline GFR, the odds
ratio remained relatively unchanged (P < 0.001). The
area under the receiver operating characteristics curveTable 3. The association of urinary 8-oxodG and 8-oxoGuo with measure
Survey Follow-Up Study
Risk factora
Model 1 unadjusted Model 2 adjusted
Estimate (ml/min per
1.73 m2 per year) (95% CI) P
Estimate (ml/min
1.73 m2 per ye
Urinary 8-oxodG
Per 1 nmol/mmol 0.12 (0.29 to 0.06) 0.19 0.09
Quartile 1 0.00 (ref) 0.00
Quartile 2 0.12 (0.42 to 0.18) 0.11
Quartile 3 0.16 (0.46 to 0.13) 0.14
Quartile 4 0.24 (0.54 to 0.05) 0.20
(0.45c)
Q4 versus Q1–Q3d 0.15 (0.39 to 0.09) 0.23 0.11
Urinary 8-oxoGuo
Per 1 nmol/mmol 0.04 (0.11 to 0.03) 0.28 0.02
Quartile 1 0.00 (ref) 0.00
Quartile 2 0.09 (0.39 to 0.20) 0.06
Quartile 3 0.05 (0.24 to 0.35) 0.10
Quartile 4 0.21 (0.51 to 0.09) 0.15
(0.34c)
Q4 versus Q1–Q3d 0.20 (0.44 to 0.05) 0.12 0.17
CI, confidence interval; 8-oxodG, 8-oxo-7,8-dihydro-20-deoxyguanosine; 8-oxoGuo, 8-oxo-7,8-dih
a8-oxodG and 8-oxoGuo were normalized for urinary creatinine.
bAdjusted for sex, baseline age, height, body weight, diastolic blood pressure, high-density lipo
A1c, high-sensitivity C-reactive protein; a dichotomous variable for the weekly use of alcohol; n
of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker.
cWald test for linear trend was applied.
dPersons with 8-oxodG or 8-oxoGuo in the highest quartile compared with the lowest quartile
578for predicting low-grade albuminuria at follow-up
increased from 0.67 (95% confidence interval:
0.60–0.75) to 0.71 (95% confidence interval: 0.63–0.78)
by including 8-oxoGuoUCR (quartile 4 compared with
quartiles 1–3) in addition to all of the other variables in
model 3, resulting in a statistically improved model as
evaluated by the likelihood test (P ¼ 0.002). There
were no interactions of age, gender, fasting glucose,d GFR change rates in mixed models: The Renal Iohexol Clearance
for sex, age, weight, and height Model 3 fully adjustedb
per
ar) (95% CI) P
Estimate (ml/min per
1.73 m2 per year) (95% CI) P
(0.27 to 0.09) 0.35 0.02 (0.20 to 0.16) 0.82
(ref) 0.00 (ref)
(0.40 to 0.19) 0.08 (0.37 to 0.21)
(0.44 to 0.16) 0.09 (0.39 to 0.21)
(0.51 to 0.11) 0.08 (0.38 to 0.23)
(0.64c) (0.88c)
(0.36 to 0.14) 0.39 0.02 (0.26 to 0.23) 0.89
(0.10 to 0.05) 0.52 0.0003 (0.07 to 0.08) 0.99
(ref) 0.00 (ref)
(0.35 to 0.24) 0.02 (0.32 to 0.27)
(0.19 to 0.40) 0.17 (0.12 to 0.47)
(0.45 to 0.15) 0.02 (0.32 to 0.29)
(0.39c) (0.56c)
(0.41 to 0.08) 0.18 0.07 (0.32 to 0.17) 0.56
ydroguanosine.
protein cholesterol, low-density lipoprotein cholesterol, fasting triglycerides, hemoglobin
umber of cigarettes currently smoked; log urine albumin-to-creatinine ratio; and the use
s.
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Table 4. The association of urinary 8-oxodG and 8-oxoGuo with the risk of low-grade albuminuria in logistic regression models: The Renal




Adjusted for sex, and baseline age, weight,
and height Fully adjustedb
Odds ratio (95% CI) P Odds ratio (95% CI) P Odds ratio (95% CI) P
Urinary 8-oxodG
Per 1 nmol/mmol 1.53 (1.04–2.26) 0.03 1.33 (0.88–2.01) 0.18 1.24 (0.80–1.90) 0.34
Quartile 1 (ref) (ref) (ref)
Quartile 2 0.88 (0.37–2.11) 0.81 (0.34–1.95) 0.75 (0.31–1.81)
Quartile 3 1.28 (0.57–2.87) 1.08 (0.48–2.46) 0.92 (0.40–2.14)
Quartile 4 1.65 (0.76–3.58) 1.26 (0.56–2.84) 1.07 (0.46–2.48)
(0.41c) (0.76c) (0.54c)
Q4 versus Q1–Q3d 1.57 (0.86–2.84) 0.14 1.30 (0.71–2.41) 0.40 1.22 (0.65–2.29) 0.54
Urinary 8-oxoGuo
Per 1 nmol/mmol 1.19 (1.02–1.39) 0.03 1.18 (1.00–1.39) 0.05 1.16 (0.98–1.37) 0.09
Quartile 1 (ref) (ref) (ref)
Quartile 2 1.18 (0.47–2.94) 1.12 (0.45–2.82) 1.07 (0.42–2.72)
Quartile 3 1.22 (0.49–3.05) 1.16 (0.46–2.93) 1.14 (0.45–2.93)
Quartile 4 2.99 (1.36–6.57) 2.87 (1.28–6.44) 2.84 (1.23–6.54)
(0.009c) (0.01c) (0.02c)
Q4 versus Q1–Q3d 2.64 (1.50–4.65) 0.001 2.62 (1.48–4.65) 0.001 2.64 (1.46–4.80) 0.001
CI, confidence interval; 8-oxodG, 8-oxo-7,8-dihydro-20-deoxyguanosine; 8-oxoGuo, 8-oxo-7,8-dihydroguanosine.
8-oxodG and 8-oxoGuo were normalized for urinary creatinine.
aLow-grade albuminuria was defined as a urinary albumine-creatinine ratio >1.13 mg/mmol (>10 mg/g).
bAdjusted for sex, baseline age, height, body weight, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, fasting triglycerides, hemogloin
A1c, high-sensitivity C-reactive protein; a dichotomous variable for the weekly use of alcohol; number of cigarettes currently smoked; the use of an angiotensin-converting enzyme
inhibitor and angiotensin receptor blocker; and baseline measured glomerular filtration rate.
cWald test for linear trend was applied.
dPersons with 8-oxodG or 8-oxoGuo in the highest quartile compared with the lowest quartiles.
J Schei et al.: Urinary Markers of Oxidative Stress and Kidney Function Decline CLINICAL RESEARCHHbA1c, or hs-CRP with either 8-oxodG or 8-oxoGuo in
the models presented in Table 4.DISCUSSION
To the best of our knowledge, this is the first study to
describe the relationship between urinary markers of
oxidative stress and renal function decline using
measured GFR in a cohort from the general population.
The age-related GFR decline of 0.84 ml/min per 1.73 m2
per year found in our study is comparable with pre-
vious studies using estimated GFR.30 None of the
markers were associated with a change in the GFR
decline during the observation period, but urinary 8-
oxoGuo excretion was associated with an increased
risk of low-grade albuminuria.
Previous studies on the relationship between
oxidative stress markers and kidney function have
been mainly cross-sectional and predominantly in pa-
tients with established CKD.11–16 The plasma level of
F2-isoprostane, a marker of lipid peroxidation, has been
correlated with CKD stages and has been higher in
patients with CKD compared with healthy con-
trols,11,12,14 but only 1 of these studies found that
plasma F2-isoprostane correlated with the estimated
GFR.11 Another study reported that serum 8-oxodG
levels inversely correlated with creatinine clearance
in patients with CKD.16Kidney International Reports (2018) 3, 573–582We are aware of only 1 longitudinal study that
examined 8-oxodG or 8-oxoGuo as predictors of kidney
outcomes. Hinokio et al.31 found that 24-hour urinary
8-oxodG excretion was associated with an increased
risk of the progression of diabetic nephropathy,
defined as albuminuria, after 5 years of follow-up.
Interestingly, 8-oxodG was the strongest independent
predictor among several well-known CKD risk factors,
such as blood pressure, HbA1c, and duration of
diabetes.
The mitochondrial and nuclear DNA and RNA in
cellular pools are common targets of oxidative damage.
Guanine is the nucleic acid base most susceptible to
oxidation. In a steady state condition, the amount of
excreted 8-oxodG and 8-oxoGuo in the urine represents
the guanine oxidation rate from DNA and RNA,
respectively.19 In diabetic mice models, mitochondrial
oxidative stress is associated with increased 8-oxodG
levels from mitochondrial DNA, as measured both in
urine and in the kidneys.32,33 Moreover, the accumu-
lation of 8-oxodG in the mitochondria of the glomeruli
and an increased urinary 8-oxodG excretion were
associated with glomerular and tubular injury in mice
during Dox treatment.10 In kidney biopsies from pa-
tients with focal segmental glomerular sclerosis, similar
results of accumulation of 8-oxodG in endothelial cells
were found, but not in kidney biopsies from healthy
controls.10 Our population was relatively healthy and579
CLINICAL RESEARCH J Schei et al.: Urinary Markers of Oxidative Stress and Kidney Function Declinewe excluded persons with diabetes, cardiovascular
disease, and renal disease at entry of the study. It is
possible that the underlying mechanisms that accel-
erate the age-related GFR decline are different from
what has been reported in specific forms of kidney
disease.10,32,33
We found that urinary excretion of the oxidatively
damaged RNA marker 8-oxoGuo independently pre-
dicted incident low-grade albuminuria, even after a
multivariable adjustment, including smoking status
and baseline GFR. This finding is noteworthy because
low-grade albuminuria, defined as a UACR >1.13 mg/
mmol, predicts cardiovascular disease, CKD, and mor-
tality in the general population.25,26 Interventions with
an antioxidant treatment or diet may reduce oxidative
stress. In a randomized controlled trial, olive oil con-
sumption reduced urinary 8-oxodG excretion signifi-
cantly.34 The same study reported a considerable
difference in the urinary excretion of 8-oxodG and 8-
oxoGuo between countries in Europe, suggesting a
positive effect of diet on oxidative stress levels.34
Moreover, in a large study with elderly Danish
twins, genetic factors had little influence on the
interindividual variability of urinary 8-oxodG and 8-
oxoGuo excretion,35 which further suggests that
oxidative stress is a modifiable risk factor and a
possible target for preventive measures. However, it
remains unclear whether antioxidants can prevent GFR
decline, CKD, or CKD progression.
Urinary 8-oxoGuo excretion was not associated with
the age-related GFR decline, but it is possible that low-
grade albuminuria may precede an acceleration of GFR
decline. However, although low-grade albuminuria is a
risk factor for cardiovascular disease, it is not estab-
lished as an independent risk factor for age-related GFR
decline or incident CKD. Even longer follow-up and
repeated GFR measurements are needed to fully assess
the long-term effect of urinary 8-oxoGuo excretion on
the age-related GFR decline. Unlike 8-oxoGuo, urinary
8-oxodG excretion was not associated with incident
low-grade albuminuria in the multivariable adjusted
analyses. The reason for this discrepancy is not clear.
Urinary 8-oxodG levels were associated with age and
smoking at baseline, whereas urinary 8-oxoGuo levels
were associated with several other CKD risk factors at
baseline, including a higher hs-CRP as a marker of
inflammation. Increased levels of inflammation are
correlated with oxidative stress in CKD patients,12,14
and we recently found that a higher serum hs-CRP
concentration was associated with a more rapid GFR
decline.36 However, the association between urinary 8-
oxoGuo excretion and low-grade albuminuria remained
unchanged after a multivariable adjustment, including
hs-CRP. RNA may be more susceptible to oxidative580damage than DNA due to its single-stranded structure,
fewer protective proteins, and its intracellular location
close to the mitochondria, which produces the reactive
oxygen species.20
The primary strength of this study was the use of
GFR measurements in a large cohort from the general
population rather than an estimated GFR based on
creatinine or cystatin C. Iohexol clearance is accurate
compared with gold standard methods,24,37,38 and the
intra-individual variation in our study was lower than
in previous studies that measured GFR.38 The UACR
was measured in unfrozen urine samples. We measured
urinary levels of 8-oxodG and 8-oxoGuo using liquid
chromatography tandem mass spectrometry, which is
more reliable than enzyme-linked immunosorbent
assay methods.39 In addition, all participants were
investigated after an overnight fast, including the
withdrawal of tobacco use, which is known to influ-
ence the day-to-day variation in 8-oxodG excretion.40
This study also has some weaknesses. The generaliz-
ability is limited to relatively healthy, middle-aged
white persons and there were higher urinary levels of
8-oxoGuo among those lost to follow-up compared with
those included in the follow-up study. We used spot
urine samples instead of the gold standard 24-hour
urine samples to measure the concentrations of
8-oxodG and 8-oxoGuo. We corrected the levels of 8-
oxodG and 8-oxoGuo for urinary creatinine, which
reduces the intra-individual variation and is shown to
correlate strongly with 24-hour urine samples.39
We conclude that higher urinary excretion of
oxidatively damaged RNA was associated with an
increased risk of incident low-grade albuminuria, but
the urinary excretion of oxidatively damaged DNA and
RNA were not associated with the age-related GFR
decline during almost 6 years of follow-up. Studies
with an even longer follow-up period and repeated
GFR measurements are needed to fully evaluate the
long-term effect of oxidative stress on the GFR decline
in the general population.DISCLOSURE
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